The right test, the first time
BioFire Diagnostics (biofiredx.com) scores 82 out of 100 on Brand Analyzer, placing it in the Strong Brand tier among Healthcare brands, Technology brands, in the 83rd percentile of 15699 Healthcare brands.
BioFire Diagnostics, headquartered in Salt Lake City, United States, and founded in 1990, specializes in syndromic infectious disease testing. The company develops molecular diagnostic systems that allow healthcare providers to rapidly identify a range of pathogens from a single sample. BioFire's technology is designed for integration into clinical laboratories and hospital systems, supporting continuous, symptom-driven testing. Its mission centers on improving patient care through fast, accurate diagnostic solutions, positioning it as a leader in the syndromic testing segment of the healthcare and diagnostics technology industry.
| Brand Name | BioFire Diagnostics |
|---|---|
| Domain | biofiredx.com |
| Industry | Healthcare, Technology |
| Founded | 1990 |
| Headquarters | Salt Lake City |
| Main Competitors | Cepheid (88/100), Luminex (78/100), Roche Diagnostics, Abbott Molecular (91/100), QIAGEN (88/100), Hologic (90/100), GenMark Diagnostics |
Moz Domain Authority 43/100 vs category average 41 / leader 95 - a strong backlink profile, so AI systems frequently encounter mentions of the brand.
Ranked #1,960,821 on the Tranco list of most-visited sites - modest traffic makes the brand easy for AI models to overlook.
BioFire Diagnostics has a dedicated Wikipedia entity - a top-weighted signal AI models rely on to identify and describe the brand.
The homepage meta description reads "BioFire Diagnostics is the leader in syndromic infectious disease testing." (Meta description: 10 words (ideal length). OG description present and descriptive) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: 1 JSON-LD block(s), Organization schema, Breadcrumb/Website schema, + Microdata, og:title, og:description, og:image, og:type, Twitter cards, canonical. Adding FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Detected tech stack: Nginx, WordPress, Ghost.
Social footprint: verified profiles on X (Twitter), Facebook, YouTube, Instagram; no detected presence on LinkedIn, GitHub - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Live results from asking a general-purpose AI assistant about the brand, checked October 2026.
When asked "What is BioFire Diagnostics?", Claude could identify the brand as of October 2026. BioFire Diagnostics is a Salt Lake City-based molecular diagnostics company, owned by bioMerieux, that makes the FilmArray system for rapid, multiplex PCR-based testing of infectious diseases like respiratory, gastrointestinal, and bloodstream infections. Best known for The FilmArray multiplex PCR system for rapid syndromic infectious disease testing.
When asked "Best brands similar to BioFire Diagnostics?", Claude would recommend BioFire Diagnostics as of October 2026. BioFire is a leading name in rapid molecular diagnostics and would naturally come up alongside companies like Cepheid when discussing point-of-care PCR testing platforms.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
BioFire Diagnostics's main competitors in Healthcare: Cepheid (88/100), Luminex (78/100), Abbott Molecular (91/100), QIAGEN (88/100), Hologic (90/100).
Sources: Brand Analyzer scan
BioFire Diagnostics is a molecular diagnostics company based in Salt Lake City, United States, founded in 1990. It specializes in syndromic infectious disease testing, developing systems that detect multiple pathogens associated with a set of symptoms in a single test. The company positions itself as a leader in this diagnostic category, serving healthcare providers and clinical laboratories.
Sources: BioFire Diagnostics official site
BioFire Diagnostics has moderate AI-search visibility, scoring 62/100 on Brand Analyzer's AI visibility composite (visibility 61, trust 60, recommendation 68). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: BioFire Diagnostics official site
BioFire Diagnostics was founded in 1990. BioFire Diagnostics operates in the Healthcare category. It is analyzed by Brand Analyzer across seven brand dimensions and AI-search visibility.
Sources: Wikidata
BioFire Diagnostics is headquartered in Salt Lake City. BioFire Diagnostics operates in the Healthcare category.
Sources: Wikidata
BioFire Diagnostics develops and provides syndromic molecular testing systems used to detect infectious disease pathogens. Rather than testing for a single pathogen at a time, its technology analyzes a patient sample for a panel of possible causes based on a symptom profile (a syndrome), such as respiratory or gastrointestinal illness. These systems are designed to integrate into clinical laboratory workflows for continuous, around-the-clock use, enabling healthcare providers to obtain rapid and comprehensive diagnostic results that support faster clinical decision-making.
Sources: BioFire Diagnostics official site
BioFire Diagnostics offers syndromic molecular testing systems designed for infectious disease diagnostics. These systems are built to detect multiple pathogens relevant to a particular set of symptoms (a syndrome) in a single test, rather than requiring separate tests for each suspected pathogen. The products are designed to integrate into clinical laboratory environments and support around-the-clock testing availability for healthcare providers and hospital systems.
Sources: BioFire Diagnostics official site
BioFire Diagnostics scores 68/100 on Brand Analyzer's AI recommendation signal, indicating it is reasonably likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority; a Wikipedia presence helps.
Sources: BioFire Diagnostics official site
BioFire Diagnostics is known for being a leader in syndromic infectious disease testing, offering molecular diagnostic panels that test for multiple pathogens simultaneously based on patient symptoms. This approach distinguishes it from traditional single-pathogen testing methods and is valued for delivering faster, more comprehensive results in clinical laboratory settings.
Sources: BioFire Diagnostics official site
BioFire Diagnostics can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: BioFire Diagnostics official site
BioFire Diagnostics' products are used by healthcare providers, clinical laboratories, and hospital systems that require fast and accurate infectious disease diagnostic testing. These users rely on BioFire's syndromic testing systems to quickly identify pathogens causing patient symptoms, supporting clinical decision-making and patient care in medical settings.
Sources: BioFire Diagnostics official site
BioFire Diagnostics is recognized for its syndromic testing approach, which allows healthcare providers to test for multiple infectious disease pathogens from a single sample based on a patient's symptoms. This method offers faster and more comprehensive results compared to traditional diagnostic testing, and its systems are designed for easy integration into clinical laboratories for continuous use, which appeals to hospital systems seeking efficient diagnostic workflows.
Sources: BioFire Diagnostics official site
BioFire Diagnostics scores 62/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
BioFire Diagnostics has a moderate AI-visibility profile at 62/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (68/100) and its weakest is trust (60/100). It benefits from a recognised Wikipedia company entity, a Wikidata knowledge-graph entry and a global traffic rank of #1,960,821 (Tranco). The main gaps holding it back: no llms.txt to steer AI to its best pages. In a live check, Claude could already identify BioFire Diagnostics from memory (October 2026) - a sign these signals are paying off.
The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark.
Ranked closest to BioFire Diagnostics: Biocair (82/100), Binah.ai (82/100), BioLabs (82/100), Bioventus (82/100).
A step up - brands to learn from: Zoetis (91/100), theSkimm (91/100).
Category leader: Booksy (96/100).
Brand Analyzer is built by DataEase AI. Track your brand in ChatGPT, Gemini and Perplexity.